Lupus enteritis: Clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody

Lupus

Volumn 16, Issue 10, 2007, Pages 803-809

  Kwok, S K ^a   Seo, S H ^a   Ju, J H ^a   Park, K S ^a   Yoon, C H ^a   Kim, W U ^a   Min, J K ^a   Park, Sung Hwan ^a,b   Cho, C S ^a   Kim, H Y ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Anti endothelial cell antibody; Anti phospholipid syndrome; Lupus enteritis; Systemic lupus erythematosus

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; PREDNISOLONE; STEROID;

ABDOMINAL PAIN; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ENTERITIS; FEMALE; HUMAN; LUPUS ENTERITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABDOMINAL PAIN; ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CASE-CONTROL STUDIES; ENTERITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDNISOLONE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STEROIDS;

EID: 35948995431     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307082383     Document Type: Article

References (34)

1. Lian TY, Edwards CJ, Chan SP, Chng HH. Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital. Lupus 2003; 12: 612-616.
2. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 917-932.
3. Prouse PJ, Thompson EM, Gumpel JM. Systemic lupus erythematosus and abdominal pain. Br J Rheumatol 1983; 22: 172-175.
4. Reynolds JC, Inman RD, Kimberly RP, Chuong JH, Kovacs JE, Walsh MB. Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature. Medicine (Baltimore) 1982; 61: 25-32.
5. Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med 1997; 103: 100-105.
6. Lee CK, Ahn MS, Lee EY et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 2002; 61: 547-550.
7. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6: 235-242.
8. Buck AC, Serebro LH, Quinet RJ. Subacute abdominal pain requiring hospitalization in a systemic lupus erythematosus patient: a retrospective analysis and review of the literature. Lupus 2001; 10: 491-495.
9. Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 1982; 73: 525-531.
10. Praprotnik S, Rozman B, Blank M, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wen Klin Wochenschr 2000; 112: 660-664.
11. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000; 20: 1-7.
12. Park MC, Park YB, Jung SY, Lee KH, Lee SK. Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: correlations of their titers and isotype distributions with disease activity. Clin Exp Rheumatol 2006; 24(2, Suppl 41): S10-S16.
13. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
14. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
15. Byun JY, Ha HK, Yu SY et al. CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology 1999; 211: 203-209.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
17. Shapeero LG, Myers A, Oberkircher PE, Miller WT. Acute reversible lupus vasculitis of the gastrointestinal tract. Radiology 1974; 112: 569-574.
18. Yokoi K, Hosoi E, Akaike M, Shigekiyo T, Saito S. Takayasu's arteritis associated with antiphospholipid antibodies: report of two cases. Angiology 1996; 47: 315-319.
19. Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998; 25: 1730-1736.
20. Tomizawa K, Sato-Matsumura KC, Kajii N. The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies. Br J Dermatol 2003; 149: 439-441.
21. Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schonlein purpura. Br J Dermatol 2006; 155: 983-987.
22. Rees JD, Lanca S, Marques PV et al. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis 2006; 65: 109-111.
23. Hebbar M, Lassalle P, Delneste Y et al. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren's syndrome. Ann Rheum Dis 1997; 56: 230-234.
24. Eichhorn J, Sima D, Lindschau C et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998; 315: 17-23.
25. Jamin C, Dugue C, Alard JE et al. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum 2005; 52: 4028-4038.
26. Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem 2006; 42: 297-326.
27. D'Cruz DP, Houssiau FA, Ramirez G et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991; 85: 254-261.
28. Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. Q J Med 1993; 86: 727-734.
29. Conti F, Alessandri C, Bompane D et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 2004; 6: R366-R372.
30. Renaudineau Y, Dugue C, Dueymes M, Youinou P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002; 1: 365-372.
31. Kim YG, Ha HK, Nah SS, Lee CK, Moon HB, Yoo B. Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis. Ann Rheum Dis 2006; 65: 1537-1538.
32. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39: 9-22.
33. Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum 1988; 31: 632-641.
34. Kishimoto M, Nasir A, Mor A, Belmont HM. Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus. Lupus 2007; 16: 137-141.